Biography & Education

“I view myself as partner and advisor to my patients and their family members.  I understand that a cancer diagnosis and treatment can be overwhelming and I believe that it is my role to provide education and guidance, so that every patient and their family may have an integral part in the decision making process.”

Kelly Perlewitz, M.D.
Areas of expertise

Medical oncology, hematology, cancer research, clinical trials

  • Bachelor of Science Electrical Engineering from Cornell University College of Engineering in Ithaca, New York
  • Medical Degree from the Robert Wood Johnson Medical School in New Brunswick, New Jersey.
  • Internship and Residency in Internal Medicine from Temple University Hospital, Department of Internal Medicine in Philadelphia, Pennsylvania
  • Fellowship in hematology and medical oncology at Oregon Health and Science University in Oregon

Board Certified:

  • Internal Medicine
  • Medical Oncology
  • Hematology

Care Locations

1003 Providence Drive
Suite 310
Newberg, OR 97132
Fax 503-537-6045


Board Certifications
  • Hematology
  • Internal medicine
  • Medical oncology
Conditions Treated
Adrenal gland cancer, Airway tumor, Anal cancer, Anemia, Antithrombin deficiency, Astrocytic tumors, Atypical ductal hyperplasia, Bile duct cancer, Bladder cancer, Bone cancer, metastatic or recurrent, Brain tumor, BRCA1 and BRCA2 breast cancer, Breast cancer, Cancer, Cancer pain, Cervical cancer, Chest wall tumor, Colon cancer, Deep vein thrombosis, Ductal carcinoma in situ, Duodenal cancer, Esophageal cancer, Gallbladder cancer, Gastroesophageal junction cancer, Gastrointestinal carcinoid tumors, Hemochromatosis, Her2 Neu breast cancer, Hereditary breast and ovarian cancer, Hereditary colon cancer, Hodgkin lymphoma, Hypopharyngeal cancer, Inflammatory breast cancer, Invasive carcinoma of the breast (IDC), Islet cell tumors (endocrine pancreas), Laryngeal cancer, Leukemia, Leukocytosis, Leukopenia, Lip and oral cavity cancer, Liver cancer, Lobular carcinoma in situ, Lung cancer, Lung metastasis, Male breast cancer, Mediastinal tumor, Melanoma, metastatic, Meningioma, Mesothelioma, Metastatic squamous neck cancer with occult primary, Multiple myeloma, Myeloproliferative diseases, Nasopharyngeal cancer, Neuroendocrine tumors, Non-Hodgkin lymphoma, Non-small cell lung cancer, Oligodendroglial tumors, Oropharyngeal cancer, Osteosarcoma, Ovarian cancer, Pancreatic cancer, Paranasal sinus and nasal cavity cancer, Polycythemia vera, Primary myelofibrosis, Prostate cancer, Pulmonary embolism, Rectal cancer, Renal cell cancer, Salivary gland cancer, Sarcoma, adult soft tissue cancer, Sickle cell disease, Skin cancer, Small cell lung cancer, Testicular Cancer, Testis cancer, Thoracic malignancy, Thrombocytopenia, Thymoma and thymic carcinoma, Thyroid cancer, Tongue cancer, Tracheal cancer, Uterine cancer, Vaginal cancer, Vulvar cancer


Patient Ratings and Comments
About Our Survey

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey. Responses are measured on a 10-point scale, with 10 being the best score. These scores are then translated to a 5-point scale in order to display results in a 5-star rating. Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.

4.8 out of 5 (53 Ratings, 0 Comments)